Related Experiment Videos

[Delayed atrial excitation following bifocal pacemaker stimulation]

Zeitschrift Fur Kardiologie
|April 1, 1983
PubMed

Insights

DDD pacemaker therapy effectively managed drug-resistant ventricular tachycardia in a patient with heart failure. Optimal results required personalized, prolonged atrioventricular intervals, demonstrating the need for individualized pacemaker settings.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Electrophysiology

Background:

  • Drug-resistant ventricular tachycardia in ischemic heart disease with severe left ventricular failure presents a significant therapeutic challenge.
  • Standard treatments often prove insufficient, necessitating advanced pacing strategies.

Observation:

  • A patient with these conditions was treated with a DDD pacemaker system set at 90 beats/min for overdrive suppression.
  • High-dose beta-blocker therapy was also administered.
  • Electrocardiogram (ECG) revealed a 100 ms delay between the atrial spike and P-wave, indicating ineffective atrial contraction.

Findings:

  • Hemodynamic effects of the ineffective atrial contraction were evaluated using various monitoring techniques.
  • Positive effects of physiological pacing were achieved only by further prolonging the atrioventricular (AV) interval by 100 ms.
  • This suggests that optimal AV intervals can vary significantly between individuals.

Implications:

  • The study highlights that DDD pacemakers may require individually tailored, prolonged AV intervals for optimal physiological pacing.
  • This finding is crucial for optimizing pacing modes like VAT, VDD, and DVI in specific patient cases.
  • Individualized programming is key to maximizing the benefits of pacemaker therapy in complex cardiac conditions.

Related Concept Videos